4
Changes in Ownership
CytomX Therapeutics, Inc. Filed Acc 0001140361-15-046030
Chief Scientific Officer and acquired 8,917 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Kavanaugh William Michael · Chief Scientific Officer and
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-12-31 | Exercise or conversion : show line 1 in the form | +8,917 | $6.61 | $58,983 | 13,917 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2015-12-31 | Exercise or conversion : show line 2 in the form Employee Stock Option (right to buy) | −8,917 | 76,688 | D |
Loading xslF345X03/doc1.xml…